Eindhoven-based medical device startup Sirius Medical has raised €10 million, led by Invest-NL and Nextgen Ventures, with support from De Groot Family Office. The funds will enable the startup to enhance the Sirius Pintuition system and GPSDetect™ software platform.
- Founded in 2017 as a spin-off from the Netherlands Cancer Institute, Sirius Medical develops surgical tools for precise tumor localization, helping surgeons and radiologists remove tumors more accurately and efficiently.
- Sirius Medical develops two products for tumor localization. Sirius Pintuition is a wire-free system that uses a small magnetic seed to help surgeons accurately locate and remove tumors. It is a precise, simple, and cost-effective solution, approved with both CE marking and FDA clearance.
- Sirius Perception enhances surgical precision by providing real-time audio and visual guidance. According to the company, its technology is used in over 250 centers worldwide, with more than 35,000 procedures performed.
Details of the deal
- The fresh capital was led by Invest-NL, an Amsterdam-based impact investment firm that supports innovative and sustainable entrepreneurial ventures in the Netherlands, and Nextgen Ventures, a Dutch-based VC that supports healthcare startups.
“Sirius Medical’s mission to develop sustainable technology solutions while maintaining balance within the healthcare system closely aligns with our mission to accelerate the healthcare transition. We are excited to back a company making such a meaningful difference for women with breast cancer," claims Karin Steffens, senior investment manager at Invest-NL.
- The investment included participation from De Groot Family Office and existing investors Brabant Development Agency (BOM), Holland Capital, Curie Capital, Team Holmium, and the Sirius Medical team.
- Sirius Medical will use the €10 million funding to enhance its Sirius Pintuition platform, expand into new markets, and strengthen sales infrastructure. The investment will also support further research and development, helping drive innovation and growth in cancer care.
“This funding round, in the current fundraising environment, is a clear testament to the talent of the Sirius Medical team, and the Pintuition technology that we have developed. We are proud to continue contributing to the fight against cancer and look forward to the next phase of growth for Sirius Medical," CEO of Sirius Medical, Bram Schermers, commented.
